Chemical Biology & Medicinal Chemistry

The graduate portfolio program in pharmacoengineering is an interdisciplinary effort that bridges expertise in pharmaceutics, chemistry, engineering, biochemistry, biologics and drug metabolism. The goal is to use new technology to develop next-generation, personalized treatments to ensure patients receive optimal dosages delivered to the precise part of the body that needs help — reducing harmful side effects and increasing their efficacy. The program is a collaboration between the Cockrell School of Engineering, College of Natural Sciences and College of Pharmacy.

Kimberly J. Long, a Ph.D. candidate in the Dalby Lab in the Division of Chemical Biology and Medicinal Chemistry, was a first author of a recent research paper published in the Proceedings of the National Academy of Sciences (PNAS).

The University of Texas at Austin College of Pharmacy earns accolades for Best in Community Engagement, Best in Health Innovation, Best Project in Progress, Best in Visual and top 3 for People’s Choice Award at the Interprofessional Health Showcase 2023.

The Cancer Prevention and Research Institute of Texas granted UT’s Lee Lab $1 million to strengthen skin cancer research last month following breakthroughs in understanding how melanoma develops.

The Cancer Prevention and Research Institute of Texas (CPRIT) has released its grant research funding awards for the upcoming year. All three awarded research projects at The University of Texas at Austin involve College of Pharmacy faculty.

The Cancer Prevention and Research Institute of Texas (CPRIT) recently awarded grants to six faculty members at UT Austin, including the Division of Chemical Biology and Medicinal Chemistry's Kevin Dalby, Ph.D. for his Targeted Therapeutic Drug Discovery and Development Program.

The college's new Building Our Own Talent (BOOT) program is designed to provide mentoring and support for trainees and embrace the notion that innovation and discovery thrive in an inclusive culture that values diverse ideas. This year’s recipients enter the pharmaceutical sciences graduate program: Charlene Mandimutsira joins the chemical biology and medicinal chemistry (CBMC) track and Kelsey Strey joins the pharmacotherapy (PT) track.